• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma?

作者信息

Zhang C-Y, He Z-H, Ahir B-K, Luo C-P, Peng N-F, Li L-Q

机构信息

Experimental Department, Affiliated Tumor Hospital of Guangxi Medical University, Nanning, China.

Department of Hepatobiliary Surgery, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, China.

出版信息

Aliment Pharmacol Ther. 2017 Jan;45(1):181-182. doi: 10.1111/apt.13814.

DOI:10.1111/apt.13814
PMID:27910145
Abstract
摘要

相似文献

1
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma?信函：对于慢性感染乙型肝炎病毒且患肝细胞癌风险较低的个体，是否应推荐抗病毒治疗？
Aliment Pharmacol Ther. 2017 Jan;45(1):181-182. doi: 10.1111/apt.13814.
2
Letter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply.信件：对于慢性感染乙型肝炎病毒且肝细胞癌风险较低的个体，是否应推荐抗病毒治疗？作者回复。
Aliment Pharmacol Ther. 2017 Jan;45(1):182-183. doi: 10.1111/apt.13849.
3
Letter to the Editor: Effect of pre-transplant viral therapy on post-transplant hepatitis B virus reactivation in patients with hepatitis B-related hepatocellular carcinoma.致编辑的信：移植前病毒治疗对乙型肝炎相关肝细胞癌患者移植后乙型肝炎病毒再激活的影响
Int J Surg. 2024 Aug 1;110(8):5270-5271. doi: 10.1097/JS9.0000000000001553.
4
High viral load is associated with poor overall and recurrence-free survival of hepatitis B virus-related hepatocellular carcinoma after curative resection: a prospective cohort study.高病毒载量与乙肝病毒相关肝细胞癌根治性切除术后总体生存率及无复发生存率低相关：一项前瞻性队列研究
Eur J Surg Oncol. 2012 Aug;38(8):683-91. doi: 10.1016/j.ejso.2012.04.010. Epub 2012 May 22.
5
Global elimination of viral hepatitis and hepatocellular carcinoma: opportunities and challenges.全球消除病毒性肝炎和肝细胞癌：机遇与挑战。
Gut. 2018 Apr;67(4):595-598. doi: 10.1136/gutjnl-2017-315407. Epub 2018 Jan 24.
6
How does hepatitis B virus infection react to hepatocellular carcinoma treatment?乙型肝炎病毒感染对肝细胞癌治疗有何反应？
J Gastroenterol Hepatol. 2012 Jan;27(1):1-2. doi: 10.1111/j.1440-1746.2011.06950.x.
7
Management of hepatitis B virus infection during treatment for hepatitis B virus-related hepatocellular carcinoma.乙型肝炎病毒相关肝细胞癌治疗期间的乙型肝炎病毒感染管理
World J Gastroenterol. 2015 Jul 21;21(27):8249-55. doi: 10.3748/wjg.v21.i27.8249.
8
Carriers of inactive hepatitis B virus are still at risk for hepatocellular carcinoma and liver-related death.携带不活动乙肝病毒的人仍然有患肝细胞癌和与肝脏相关死亡的风险。
Gastroenterology. 2010 May;138(5):1747-54. doi: 10.1053/j.gastro.2010.01.042. Epub 2010 Jan 28.
9
Reactivated hepatitis B due to medical interventions: the clinical spectrum expands.医疗干预导致的乙型肝炎再激活：临床谱扩大。
Antivir Ther. 2011;16(7):947-9. doi: 10.3851/IMP1877.
10
Antiviral therapy and hepatitis B virus-related hepatocellular carcinoma recurrence.
JAMA. 2013 Feb 27;309(8):765-6. doi: 10.1001/jama.2013.571.